Activest Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Activest Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$31.4K	Buy	60 +2	+3%	+$1.02K	0.01%	348
2026 Q2	$28.8K	Buy	58 +12	+26%	+$5.32K	0.01%	363
2026 Q1	$20.6K	Buy	46 +40	+667%	+$18.7K	﹤0.01%	518
2025 Q4	$2.93K	Sell	6 -10	-63%	-$4.31K	﹤0.01%	841
2025 Q3	$6.13K	Sell	16 -106	-87%	-$44.3K	﹤0.01%	601
2025 Q2	$54.1K	Buy	122 +71	+139%	+$32.7K	0.01%	200
2025 Q1	$24.7K	Buy	+51	New	+$23.8K	0.01%	266
2023 Q3	–	Sell	-116	Closed	-$40.6K	–	401
2023 Q2	$39.8K	Buy	+116	New	+$39.1K	0.03%	101

Other funds holding VRTX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

Bank Julius Baer & Co Zurich, Switzerland $39.3B AUM 31.81% 1-Year Est. Return

ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return

Activest Wealth Management's VRTX Position: Q3 2026 in Review

Activest Wealth Management increased its Vertex Pharmaceuticals (VRTX) stake by 3.4% in Q3 2026, buying an estimated $1.02K and bringing the position to 60 shares worth $31.4K. The position accounts for 0.01% of the portfolio, ranked #348.

Activest Wealth Management first reported a position in VRTX in Q2 2023 and has held it in 8 quarters since. The position peaked at $54.1K in Q2 2025. 754 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

Activest Wealth Management held 60 shares of Vertex Pharmaceuticals worth $31.4K as of Q3 2026.
Activest Wealth Management bought 2 Vertex Pharmaceuticals shares in Q3 2026, an estimated $1.02K.
Vertex Pharmaceuticals made up 0.01% of Activest Wealth Management's portfolio in Q3 2026, its #348 holding.
Activest Wealth Management first reported a position in Vertex Pharmaceuticals in Q2 2023 and has held it in 8 quarters since.
Activest Wealth Management's Vertex Pharmaceuticals position peaked at $54.1K in Q2 2025.
754 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Activest Wealth Management's 13F filing for Q3 2026, filed 15 Oct 2026.